Atripla to Raltegravir Switch Study for CNS Toxicity

计划入组 40 人 · 首次发布于 2010 年 9 月 6 日

Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity

计划入组 40 人 · 首次发布于 2014 年 11 月 7 日

Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers

计划入组 91 人 · 首次发布于 2018 年 2 月 14 日

beta-glucuronidase inhibitors (toxicity)

CNS-1261 (PAION)

Uridine triacetate(Vistogard, Xuriden)

C₁₅H₁₈N₂O₉

CNS Pharmaceuticals

United States

CNS NETWORK INC

United States

CNS Pharmaceuticals Inc.

Belgium

28bio's CNS-3D Brain Organoids Demonstrate Superior Seizure Prediction Accuracy Over Animal Models

Quiver Bioscience Secures $2.15M NIH Grant to Develop AI-Powered CNS Drug Safety Platform

Palisade Bio's PALI-2108 Shows Promise in Ulcerative Colitis Preclinical Studies